Ultrastructural changes of platelets and fibrin networks in human asthma: A qualitative case study

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 2, 2009, Pages 146-149

  Pretorius, Etheresia ^a   Oberholzer, Hester M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

BALB c murine asthma model; Fibrin network; Human asthma; Platelets; Scanning electron microscopy

Indexed keywords

FIBRIN; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALBUTAMOL;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CASE REPORT; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FIBRIN CLOT; HUMAN; LUNG FUNCTION TEST; MALE; MOUSE; NONHUMAN; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PSEUDOPODIUM; THROMBOCYTE AGGREGATION;

ADOLESCENT; ADULT; ANIMALS; ASTHMA; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; FEMALE; FIBRIN; HUMANS; MALE; MICE; MICE, INBRED BALB C;

EID: 62349094301     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328325549a     Document Type: Article

References (14)

1. Pitchford SC, Yano H, Lever R, Riffo-Vasquez Y, Ciferri S, Giannini S, et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 2003; 112:109-118.
2. Pitchford SC, Momi S, Baglioni S, Casali L, Giannini S, Rossi R, et al. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am J Respir Crit Care Med 2008; 77:604-612.
3. Pretorias E, Ekpo OE, Smit E. Comparative ultrastructural analyses of platelets and fibrin networks using the murine model of asthma. Exp Toxicol Pathol 2007a; 59:105-114.
4. Pitchford SC. Defining a role for platelets in allergic inflammation. Biochem Soc Trans 2007; 35 (R 5):1104-1108.
5. Pitchford SC, Riffo-Vasquez Y, Sousa A, Momi S, Gresele P, Spina D, Page CP. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 2004; 103:639-647.
6. Morley J, Sanjar S, Page CP. The platelet in asthma. Lancet 1984; 1:1142-1144.
7. Epstein MM. Do mouse models of allergic asthma mimic clinical disease? Int Arch Allergy Immunol 2004; 133:84-100.
8. Epstein MM. Modelling allergic asthma: in vitro assays to virtual patients. Drug Discov Today Dis Models 2004; 1:387-394.
9. Pretorius E, Briedenhann S, Marx J, Smit E, van der Merwe CF, Pieters M, Franz RC. Ultra-structural comparison of the morphology of three different platelet and fibrin fiber preparations. Anatom Record 2007; 290:188-198.
10. Pretorius E, Briedenhann S, Marx J, Franz RC. Structural changes in the fibrin network of a Pretoria family with dysfibrinogenaemia: a scanning electron microscopical study. Ultrastruct Pathol 2006; 30:167-176.
11. Pretorius E, Humphries P, Ekpo OE, Smit E, van der Merwe CF. Comparative ultrastructural analyses of mouse, rabbit and human platelets and fibrin networks. Microsc Res Tech 2007; 70:823-827.
12. Banach-Wawrzenczyk E, Dziedziczko A, Rosc D. Fibrinolytic system in bronchial asthma after prednisone treatment. Pol Merkuriusz Lek 2000; 7:9-11.
13. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154:308-317.
14. Wagers S, Norton RJ, Rinaldi LM, Bates JHT, Sobel BE, Irvin CG. Extravascular fibrin plasminogen activator plasminogen activator inhibitors and airway hyperresponsiveness. J Clin Invest 2004; 1141:104-111.